
    
      To assess whether six week treatment with BID topical Menthol application will decrease
      persistent neuropathic pain as measured by the change in Brief Pain Inventory-Short Form
      (BPI-SF worst pain score), following neoadjuvant/adjuvant chemotherapy with taxanes or
      oxaliplatin-based regimens among breast and colorectal cancer patients.
    
  